Skip to main content
GutCited

Inulin Figures

49 figures from peer-reviewed research

All Aloe Vera (Inner Leaf Gel) Alpha-Galactosidase Bacillus coagulans Berberine Bifidobacterium bifidum Bifidobacterium lactis Bifidobacterium longum Bovine Colostrum Butyrate (Sodium/Calcium Butyrate) Curcumin Fructooligosaccharides (FOS) Galactooligosaccharides (GOS) Ginger Inulin Lactase Lactobacillus acidophilus Lactobacillus gasseri Lactobacillus plantarum L-Glutamine Medium-Chain Triglycerides (MCT Oil) N-Acetyl Cysteine (NAC) Omega-3 Fatty Acids (EPA/DHA) Pancreatic Enzymes (Pancrelipase) Peppermint Oil Psyllium Husk Saccharomyces boulardii Vitamin A Vitamin D Zinc
All Types Chart Diagram Photograph Flowchart Forest Plot Micrograph Other
Figure 2
Figure 2 Chart

Metabolomic analysis of fecal samples following inulin intervention reveals significant changes in short-chain fatty acid profiles, particularly increased butyrate and propionate concentrations. These metabolic shifts correlate with specific microbial community changes.

Prebiotic inulin-type fructans induce specific changes in the human gut microbiota.

Figure 3
Figure 3 Chart

Gut microbiota composition changes induced by inulin-type fructans are characterized by increased abundance of Bifidobacterium, Faecalibacterium, and Anaerostipes, alongside decreased levels of Bilophila. These shifts are associated with altered fecal metabolite profiles.

Prebiotic inulin-type fructans induce specific changes in the human gut microbiota.

Figure 1
Figure 1 Diagram

Inflammatory bowel disease pathogenesis involves interplay between genetic susceptibility, environmental factors, immune dysregulation, and gut microbiota alterations. Prebiotics, probiotics, and synbiotics target the microbial component of this multifactorial pathway.

Role of prebiotics, probiotics, and synbiotics in management of inflammatory bowel disease: …

Figure 2
Figure 2 Diagram

Prebiotics serve as selective substrates for beneficial gut bacteria, promoting the growth of health-associated species such as Bifidobacterium and Lactobacillus. Common prebiotics include inulin, fructooligosaccharides, and galactooligosaccharides.

Role of prebiotics, probiotics, and synbiotics in management of inflammatory bowel disease: …

Figure 3
Figure 3 Diagram

Probiotic mechanisms of action in IBD include strengthening the intestinal epithelial barrier, competing with pathogenic bacteria for adhesion sites, and modulating both innate and adaptive immune responses.

Role of prebiotics, probiotics, and synbiotics in management of inflammatory bowel disease: …

Figure 4
Figure 4 Diagram

Synbiotics combine probiotics with prebiotics to achieve synergistic effects on gut health. The prebiotic component selectively nourishes the co-administered probiotic strain, potentially enhancing its colonization and metabolic activity.

Role of prebiotics, probiotics, and synbiotics in management of inflammatory bowel disease: …

Figure 5
Figure 5 Chart

Clinical evidence for probiotic efficacy in ulcerative colitis is stronger than for Crohn's disease, with certain multi-strain formulations showing benefit in maintaining remission. Strain-specific effects are critical, as not all probiotics demonstrate equivalent therapeutic potential.

Role of prebiotics, probiotics, and synbiotics in management of inflammatory bowel disease: …

Figure 6
Figure 6 Chart

Gut microbiota composition in IBD patients is characterized by reduced diversity, decreased Firmicutes abundance, and increased representation of potentially pathogenic Proteobacteria. Probiotic interventions aim to partially normalize these patterns.

Role of prebiotics, probiotics, and synbiotics in management of inflammatory bowel disease: …

Figure 7
Figure 7 Chart

Fecal calprotectin and other inflammatory biomarkers may serve as objective measures for monitoring probiotic treatment response in IBD patients. Reductions in these markers correlate with clinical improvement in several studies.

Role of prebiotics, probiotics, and synbiotics in management of inflammatory bowel disease: …

Figure 1
Figure 1

Summary of systematic review findings on over-the-counter therapies for chronic constipation, synthesizing evidence from randomized controlled trials evaluating fiber supplements, osmotic laxatives, and stimulant laxatives.

Efficacy and Safety of Over-the-Counter Therapies for Chronic Constipation: An Updated Systematic …

Figure 3
Figure 3 Chart

In vitro or in vivo efficacy data for the inulin hydrogel system, evaluating anti-inflammatory and anti-fibrotic effects in intestinal tissue models.

Ternary inulin hydrogel with long-term intestinal retention for simultaneously reversing IBD and …

Figure 4
Figure 4 Chart

In vitro or in vivo efficacy data for the inulin hydrogel system, evaluating anti-inflammatory and anti-fibrotic effects in intestinal tissue models.

Ternary inulin hydrogel with long-term intestinal retention for simultaneously reversing IBD and …

Figure 5
Figure 5 Chart

In vitro or in vivo efficacy data for the inulin hydrogel system, evaluating anti-inflammatory and anti-fibrotic effects in intestinal tissue models.

Ternary inulin hydrogel with long-term intestinal retention for simultaneously reversing IBD and …

Figure 6
Figure 6 Chart

Therapeutic outcome measurements from the DSS-induced colitis model treated with the inulin hydrogel, assessing colon histology, inflammatory markers, and fibrosis resolution.

Ternary inulin hydrogel with long-term intestinal retention for simultaneously reversing IBD and …

Figure 10
Figure 10 Chart

Intestinal microbiome restoration data following inulin hydrogel treatment, showing probiotic-mediated recovery of microbial diversity and beneficial bacterial populations.

Ternary inulin hydrogel with long-term intestinal retention for simultaneously reversing IBD and …

Figure 11
Figure 11 Chart

Supplementary characterization or mechanistic data from the ternary inulin hydrogel study, providing additional evidence for the dual anti-inflammatory and anti-fibrotic therapeutic approach.

Ternary inulin hydrogel with long-term intestinal retention for simultaneously reversing IBD and …

Figure 12
Figure 12 Chart

Supplementary characterization or mechanistic data from the ternary inulin hydrogel study, providing additional evidence for the dual anti-inflammatory and anti-fibrotic therapeutic approach.

Ternary inulin hydrogel with long-term intestinal retention for simultaneously reversing IBD and …

Figure 13
Figure 13 Chart

Supplementary characterization or mechanistic data from the ternary inulin hydrogel study, providing additional evidence for the dual anti-inflammatory and anti-fibrotic therapeutic approach.

Ternary inulin hydrogel with long-term intestinal retention for simultaneously reversing IBD and …

Figure 14
Figure 14 Chart

Supplementary characterization or mechanistic data from the ternary inulin hydrogel study, providing additional evidence for the dual anti-inflammatory and anti-fibrotic therapeutic approach.

Ternary inulin hydrogel with long-term intestinal retention for simultaneously reversing IBD and …

Figure 15
Figure 15 Chart

Supplementary characterization or mechanistic data from the ternary inulin hydrogel study, providing additional evidence for the dual anti-inflammatory and anti-fibrotic therapeutic approach.

Ternary inulin hydrogel with long-term intestinal retention for simultaneously reversing IBD and …

Figure 1
Figure 1

Synbiotic supplementation may globally improve non-motor symptoms in patients with stable Parkinson's …

Figure 2
Figure 2

Synbiotic supplementation may globally improve non-motor symptoms in patients with stable Parkinson's …

Figure 1. Patient flowchart.
Figure 1

Figure 1. Patient flowchart.

The effects of synbiotics on the liver steatosis, inflammation, and gut microbiome …

Figure 2. The microbiome dynamics.
Figure 2

Figure 2. The microbiome dynamics.

The effects of synbiotics on the liver steatosis, inflammation, and gut microbiome …

Page 1 of 3